
Study Points to New Treatment Strategy for Prostate Cancer
An Israeli-led study by Prof. Yosef Yarden at the Weizmann Institute identifies a gene fusion mechanism causing prostate cancer resistance to standard hormone.
Wednesday, 14 October 2026
Two minors were stabbed and sustained moderate injuries in a violent criminal incident in Rehovot; police are investigating.
Read More →Viktor Rachmilov, former deputy mayor of Ofakim and Likud member, joins Avigdor Liberman's Yisrael Beytenu party, citing security and economic...
Read More →A 10-year-old boy died from injuries sustained in a Beitar Illit fire and explosion, with investigators suspecting children may have...
Read More →The family of missing girl Haymanut Kasau met with Shin Bet chief David Zini, who expressed empathy and openness to...
Read More →Israel's Knesset Finance Committee approved a debt reform allowing non-bank credit card companies to issue CoCo bonds, boosting competition.
Read More →An explosive device detonated inside a moving vehicle in Netivot, southern Israel, injuring four people amid ongoing criminal feuds.
Read More →The IDF has established a multi-tier review process for awarding military and civilian honors for heroism during the October 7...
Read More →Apple allocated just 500 foldable iPhone Duo units to Israel for its initial launch, with preorders opening Oct. 16 and...
Read More →Jerusalem's District Court ordered Bank Leumi to transfer NIS 11 million from UNRWA's account to the municipality for unpaid property...
Read More →
An Israeli-led study by Prof. Yosef Yarden at the Weizmann Institute identifies a gene fusion mechanism causing prostate cancer resistance to standard hormone.